Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > pSivida cancer cure ready for human testing

April 6th, 2004

pSivida cancer cure ready for human testing

Abstract:
pSivida Limited (PSD) today announced that its Singaporean subsidiary, pSiOncology Pte Ltd has successfully completed a final pre-clinical study for its lead BioSiliconTM product, BrachySilTM. This important and final pre-clinical milestone now paves the way for a ‘first in man’ evaluation of both BioSilicon and BrachySil, they announced. BrachySil is the Company’s lead product and is targeted to the substantial brachytherapy market, which is currently worth $600 million and expected to exceed US$1 billion by 2005.

Source:
egoli

Bookmark:

Related News Press

Nanomedicine

Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013

Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Announcements

Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013

International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013

Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013

Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013